The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2019

Filed:

Jul. 14, 2015
Applicants:

Johann Wolfgang Goethe-universität, Frankfurt AM Main, Frankfurt am Main, DE;

Drk Blutspendedienst Baden-württemberg-hessen Ggmbh, Frankfurt am Main, DE;

Inventors:

Peter Bader, Dreieich, DE;

Selim Kuci, Frankfurt am Main, DE;

Zyrafete Kuci, Frankfurt am Main, DE;

Halvard Bönig, Frankfurt, DE;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0775 (2010.01); A61K 35/28 (2015.01); C12Q 1/6881 (2018.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
C12N 5/0663 (2013.01); A61K 35/28 (2013.01); C12Q 1/6881 (2013.01); A61K 2035/124 (2013.01);
Abstract

The present invention pertains to an improved mesenchymal stromal cell (MSC) preparation and a method for producing the same. The invention provides a new strategy to isolate MSC from bone marrow mononuclear cells (BM-MNCs) by pooling BM-MNCs of multiple unrelated (third-party) bone marrow donors. The MSC preparation manufactured in accordance with the methodology of the invention is characterized by a stable proliferative capability and an increased immunosuppressive potential when compared to individual donor MSC preparations or a pool of individual MSCs generated from multiple donors. The MSCs prepared ac- cording to the invention are particularly useful for medical applications such as the treatment of graft-versus-host disease (GvHD) in recipients with hematopoietic stem cell transplants, patients with autoimmune disorders and as a cell-based therapy in regenerative medicine.


Find Patent Forward Citations

Loading…